{
    "2019-05-31": [
        [
            {
                "time": "",
                "original_text": "恒瑞医药正式布局PD 研发已超5亿",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "PD研发",
                        "5亿"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2019-05",
                "original_text": "5月北上资金净流出金额再破纪录，6月A股行情如何演绎？",
                "features": {
                    "keywords": [
                        "北上资金",
                        "净流出",
                        "破纪录",
                        "A股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "起底恒瑞医药2018年研发投入主要流向",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "2018年",
                        "研发投入",
                        "流向"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药新药获批 研发费用投入超5亿元",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "新药获批",
                        "研发费用",
                        "5亿元"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2019-05-31",
                "original_text": "5月31日上市公司午间公告集锦",
                "features": {
                    "keywords": [
                        "上市公司",
                        "午间公告",
                        "集锦"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药(600276.SH)注射用卡瑞利珠单抗获新药证书和药品注册批件",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "卡瑞利珠单抗",
                        "新药证书",
                        "药品注册批件"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "午间公告：大烨智能发行股份购买资产方案未获证监会批准",
                "features": {
                    "keywords": [
                        "大烨智能",
                        "发行股份",
                        "购买资产",
                        "证监会",
                        "未批准"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "智能设备"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "午间公告：大烨智能发行股份购买资产事项未获证监会核准 再融资异常",
                "features": {
                    "keywords": [
                        "大烨智能",
                        "发行股份",
                        "购买资产",
                        "证监会",
                        "未核准",
                        "再融资异常"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "智能设备"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2019-06",
                "original_text": "新股速递 | 嘉宏教育启动分析师路演；翰森制药预计将于6月14日挂牌上市；日照港裕廊股份6日定价，19日登陆港交所",
                "features": {
                    "keywords": [
                        "嘉宏教育",
                        "翰森制药",
                        "日照港裕廊",
                        "挂牌上市",
                        "分析师路演"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "教育",
                        "医药",
                        "港口物流"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "海正药业欲卖房自救 年营收破百亿为何仍净亏4.9亿？",
                "features": {
                    "keywords": [
                        "海正药业",
                        "卖房自救",
                        "营收破百亿",
                        "净亏4.9亿"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}